MEDICAL SUPPLIES INDUSTRY – AUSTRALIA

J&J to pay $250m for bad hip joints

roymorgansocial Leave a comment

Original article by Marianna Papadakis
The Australian Financial Review – Page: 7 : 1-Apr-16

Johnson & Johnson has reached a conditional agreement with lawyers representing 1,700 Australians who allegedly suffered adverse health effects related to hip replacements. The pharmaceutical and medical devices group agreed to pay $A250 million to settle the case. The class action settlement is yet to be approved by Federal Court.

CORPORATES
JOHNSON AND JOHNSON, DEPUY AUSTRALIA, SHINE LAWYERS, MAURICE BLACKBURN PTY LTD, FEDERAL COURT OF AUSTRALIA

Trading frenzy over pot stock

roymorgansocial Leave a comment

Original article by Patrick Durkin
The Australian Financial Review – Page: 3 : 23-Jan-15

Shares in PhytoTech Medical closed at $A0.42 on 22 January 2015, after being issued at $A0.20 apiece in a $A5.9m IPO. Some 13 million shares in the group changed hands. PhytoTech will specialise in growing marijuana for medical use and the supply of medical devices for administering legal cannabis. Adam Blumenthal notes that the global medical cannabis industry is worth $A100bn at present

CORPORATES
PHYTOTECH MEDICAL LIMITED – ASX PYL, BBY LIMITED, GW PHARMACEUTICALS PLC, LONDON STOCK EXCHANGE, ASX LIMITED – ASX ASX, AUSTRALIAN SECURITIES AND INVESTMENTS COMMISSION